Like many conferences in the COVID era, DPHARM, the annual conference based in Boston and focused on disruptive innovations in clinical trials, moved from in-person to a virtual setting this week, due to local spikes of the Delta variant. To date, I’ve largely avoided these…
Translations for Clinical Trials: COVID-19 Brings Special Challenges
Right at the start of the Covid pandemic last March, my colleague Dan McDonald and I were in Germany at the Munich OECT conference. Like an awkward tingle of electricity, there was an awareness that things might be about to change. But even with sanitizers…
The documents we create for clinical trials are collections of words. Reviewing these documents can be a straightforward process, with the final draft approved after one or two rounds of changes. In clinical trial translation management, sometimes a document is improved by the edits, sometimes…
If you’ve ever had to manage a trial with underperforming enrollment levels (chances are, you have!), you know firsthand the headaches this can cause. Teams often feel overwhelmed and helpless. I first blogged about this subject in 2015. In general, clinical trial sponsors are much…